Brief: Taro Announces Commencement Of Tender Offer To Repurchase Up To $225 Million In Value Of Its Ordinary Shares
Taro Pharmaceutical Industries Ltd TARO.N :
* TARO ANNOUNCES COMMENCEMENT OF TENDER OFFER TO REPURCHASE
UP TO
$225 MILLION IN VALUE OF ITS ORDINARY SHARES
* TARO PHARMACEUTICAL INDUSTRIES - TENDER OFFER TO
REPURCHASE
ORDINARY SHARES AT PRICE NOT GREATER THAN $92.00/SHARE NOR LESS
THAN $80.00/SHARE
* TARO PHARMACEUTICAL INDUSTRIES LTD - TENDER OFFER WILL
EXPIRE AT
5:00 P.M., NEW YORK CITY TIME, ON DECEMBER 16, 2019
Source text for Eikon: ID:nBw8nCx3wa
Further company coverage: TARO.N
Recent news on Taro Pharmaceutical Industries
See all newsBrief: Taro Pharmaceutical Industries Says Taro Shareholders Approve Merger With Sun Pharma
Taro Pharmaceutical Industries Ltd reports results for the quarter ended in March - Earnings Summary
Taro Pharmaceutical Industries Ltd expected to post earnings of 31 cents a share - Earnings Preview
Ex-Sandoz exec gets probation for price-fixing after cooperation deal
Brief: ISS, Glass Lewis Recommend Taro Shareholders Vote For Merger With Sun Pharma